Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Retroviral replicating vector can extend lives of brain cancer patients

Retroviral replicating vector can extend lives of brain cancer patients

Sophisticated technology helps model and simulate optimal dose for pediatric ependymoma patients

Sophisticated technology helps model and simulate optimal dose for pediatric ependymoma patients

Researchers develop metastasis-on-a-chip system to advance cancer investigation, drug discovery

Researchers develop metastasis-on-a-chip system to advance cancer investigation, drug discovery

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

First patients treated in Phase 1b trial of pembrolizumab with REOLYSIN in advanced pancreatic adenocarcinoma

First patients treated in Phase 1b trial of pembrolizumab with REOLYSIN in advanced pancreatic adenocarcinoma

NUS-led study discovers potential therapeutic approach against colorectal cancer

NUS-led study discovers potential therapeutic approach against colorectal cancer

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Novel therapy gets FDA approval for patients with metastatic pancreatic adenocarcinoma

Novel therapy gets FDA approval for patients with metastatic pancreatic adenocarcinoma

New combination treatment approved by FDA for metastatic pancreatic cancer

New combination treatment approved by FDA for metastatic pancreatic cancer

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

Graphene coating can help boost chemotherapy treatment

Graphene coating can help boost chemotherapy treatment

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Genes could help physicians make informed treatment decisions for metastatic colorectal cancer patients

Genes could help physicians make informed treatment decisions for metastatic colorectal cancer patients

MGH-CEM researchers develop novel approach to evaluate the liver's drug-metabolizing activity

MGH-CEM researchers develop novel approach to evaluate the liver's drug-metabolizing activity

Using graphene as alternative coating for catheters to improve chemotherapy delivery

Using graphene as alternative coating for catheters to improve chemotherapy delivery

Caris Life Sciences: Study identifies benefit of targeted therapy in CRC with high microsatellite instability

Caris Life Sciences: Study identifies benefit of targeted therapy in CRC with high microsatellite instability

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer